Lack of survival advantage among re-resected elderly glioblastoma patients: a SEER-Medicare study.

MLA

Goldman, Debra A., et al. “Lack of Survival Advantage among Re-Resected Elderly Glioblastoma Patients: A SEER-Medicare Study.” Neuro-Oncology Advances, vol. 3, no. 1, Nov. 2020, p. vdaa159. EBSCOhost, https://doi.org/10.1093/noajnl/vdaa159.

APA

Goldman, D. A., Reiner, A. S., Diamond, E. L., DeAngelis, L. M., Tabar, V., & Panageas, K. S. (2020). Lack of survival advantage among re-resected elderly glioblastoma patients: a SEER-Medicare study. Neuro-Oncology Advances, 3(1), vdaa159. https://doi.org/10.1093/noajnl/vdaa159

Chicago

Goldman, Debra A, Anne S Reiner, Eli L Diamond, Lisa M DeAngelis, Viviane Tabar, and Katherine S Panageas. 2020. “Lack of Survival Advantage among Re-Resected Elderly Glioblastoma Patients: A SEER-Medicare Study.” Neuro-Oncology Advances 3 (1): vdaa159. doi:10.1093/noajnl/vdaa159.